Showing results (721-730 of 973) with videos related to
Sort By:
Pageof 98
Journal of Affective Disorders|July 5, 2021
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic reviewJason Ng, Joshua D Rosenblat, Leanna M W Lui, et al.Microbial Pathogenesis|July 10, 2024
In vitro conjugation of IncB/O-plasmid: Minimum inhibitory concentration of β-lactams increases 16-fold in Salmonella enterica compared with Escherichia coliViviane Amorim Ferreira, Mauro M S Saraiva, Isabella C Campos, et al.Journal of Affective Disorders|June 23, 2021
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|January 22, 2021
Safety, Tolerability, and Real-World Effectiveness of Intravenous Ketamine in Older Adults With Treatment-Resistant Depression: A Case SeriesOrly Lipsitz, Joshua D Di Vincenzo, Nelson B Rodrigues, et al.Plos One|September 24, 2021
The MoveStrong program for promoting balance and functional strength training and adequate protein intake in pre-frail older adults: A pilot randomized controlled trialIsabel B Rodrigues, Ellen Wang, Heather Keller, et al.International Journal of Molecular Sciences|February 26, 2025
Correction: Oliveira et al. Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in Mice. <i>Int. J. Mol. Sci.</i> 2021, <i>22</i>, 5289Sara R Oliveira, Pedro A Dionísio, Maria M Gaspar, et al.International Journal of Molecular Sciences|June 2, 2021
Discovery of a Necroptosis Inhibitor Improving Dopaminergic Neuronal Loss after MPTP Exposure in MiceSara R Oliveira, Pedro A Dionísio, Maria M Gaspar, et al.Alzheimer Disease and Associated Disorders|April 27, 2018
Effects of the Tailored Activity Program in Brazil (TAP-BR) for Persons With Dementia: A Randomized Pilot TrialMarcia M P C Novelli, Styfany C B Machado, Gabriela B Lima, et al.International Journal of Molecular Sciences|October 14, 2023
LQFM289: Electrochemical and Computational Studies of a New Trimetozine Analogue for Anxiety TreatmentJhon K A Pereira, André G C Costa, Edson S B Rodrigues, et al.Journal of Affective Disorders|May 30, 2021
Government response moderates the mental health impact of COVID-19: A systematic review and meta-analysis of depression outcomes across countriesYena Lee, Leanna M W Lui, David Chen-Li, et al.Pageof 98